Health2006 - an Observational Study of Cardiovascular Disease, Diabetes, Asthma and Allergy

The recruitment status of this study is unknown because the information has not been verified recently.

Verified January 2007 by Glostrup University Hospital, Copenhagen. Recruitment status was Recruiting

First Received on April 19, 2006. Last Updated on May 8, 2008 History of Changes

Sponsor:	Glostrup University Hospital, Copenhagen
Collaborator:	Steno Diabetes Center
Information provided by:	Glostrup University Hospital, Copenhagen
ClinicalTrials.gov Identifier:	NCT00316667

Purpose

The aim is to assess the population prevalence of risk factors for different chronic diseases such as cardiovascular disease, type 2 diabetes, osteoporosis, asthma, and allergy. Risk factors include genetic and serologic biomarkers, questionnaire data on health and lifestyle. There are many hypotheses under study for each research field.

Condition
Cardiovascular Disease Type 2 Diabetes Asthma Hypersensitivity Osteoporosis

Study Type:	Observational
Study Design:	Time Perspective: Prospective
Official Title:	Health2006 - an Observational Population-Based Study of Cardiovascular Disease, Type 2 Diabetes, Asthma and Allergy

Resource links provided by NLM:

Genetics Home Reference related topics: 6q24-related transient neonatal diabetes mellitus

MedlinePlus related topics: Allergy Asthma Diabetes Diabetes Type 2 Osteoporosis

U.S. FDA Resources

Further study details as provided by Glostrup University Hospital, Copenhagen:

Estimated Enrollment:	5000
Study Start Date:	June 2006
Estimated Study Completion Date:	June 2008

Detailed Description:

A population-based random sample of persons living in Copenhagen is drawn from the Danish Civil Registration System and invited for a health examination including blood sample drawing, measurement of lung function, serologic and genetic biomarkers, questionnaires on lifestyle and health. The study will form the basis for research within many different areas such as cardiovascular disease, type 2 diabetes, asthma, and allergy.

Eligibility

Ages Eligible for Study:	18 Years to 69 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	Yes

Criteria

Inclusion Criteria:

Persons living in 11 municipalities in Copenhagen

Exclusion Criteria:

Pregnancy
Non-Danish citizenship

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00316667

Contacts

Contact: Allan Linneberg, MD, PhD

+45 43233260

alli@glostruphosp.kbhamt.dk

Locations

Denmark
Research Centre for Prevention and Health	Recruiting
Copenhagen, Glostrup, Denmark, DK-2600
Contact: Allan Linneberg, MD, PhD +45 43233260 alli@glostruphosp.kbhamt.dk
Principal Investigator: Allan Linneberg, MD, PhD

Sponsors and Collaborators

Glostrup University Hospital, Copenhagen

Steno Diabetes Center

Investigators

Principal Investigator:

Allan Linneberg, MD, PhD

Glostrup University Hospital, Copenhagen

More Information

No publications provided

ClinicalTrials.gov Identifier:	NCT00316667 History of Changes
Other Study ID Numbers:	KA20060011
Study First Received:	April 19, 2006
Last Updated:	May 8, 2008
Health Authority:	Denmark: Ethics Committee

Keywords provided by Glostrup University Hospital, Copenhagen:

epidemiology
risk factors

Additional relevant MeSH terms:

Asthma
Cardiovascular Diseases
Diabetes Mellitus
Diabetes Mellitus, Type 2
Hypersensitivity
Osteoporosis
Bronchial Diseases
Respiratory Tract Diseases
Lung Diseases, Obstructive
Lung Diseases

Respiratory Hypersensitivity
Hypersensitivity, Immediate
Immune System Diseases
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
Bone Diseases, Metabolic
Bone Diseases
Musculoskeletal Diseases

ClinicalTrials.gov processed this record on February 12, 2012